Z Biotech, LLC
Aurora, CO
Company facts
- Self-certified in SAM.gov
- Entity structure
- Sole Proprietorship
- SAM.gov registration date
- Physical address
- 12635 E Montview Blvd #214, Aurora, CO 80045, USA
- Website
- zbiotech.com
- Founded
- 2013
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Lectenz Bio, Inc. | Athens, GA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Natglycan LLC | Tucker, GA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Glycoscientific, L.L.C. | Athens, GA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Bellbrook Labs LLC | Madison, WI | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Dotquant LLC | Shoreline, WA | — |
About the company
Z Biotech, LLC is a corporate entity registered in SAM.gov since October 2013, located in Aurora, Colorado. The company operates as a for-profit limited liability company specializing in advanced glycoscience research and development, with a focus on creating sophisticated molecular tools and analytical systems for biomedical applications. Their work primarily centers on developing innovative glycan-related technologies, probes, and research platforms that can be applied to critical areas of medical research, particularly in understanding cellular interactions, disease mechanisms, and potential diagnostic and therapeutic approaches.
Through its federal grant awards from the National Institute of General Medical Sciences (NIGMS), Z Biotech, LLC has demonstrated expertise in developing complex glycan-based research tools and technologies. The company has received multiple project grants totaling approximately $927,455, focusing on developing a comprehensive tumor-associated carbohydrate antigen (TACA) glycan library, engineering sialoglycan-recognizing probes (SGRPs), and creating a glycan binding protein-based glycosylation analysis system. These projects involve advanced molecular engineering, synthesizing specific glycans and glycopeptides, developing specialized probes for recognizing and analyzing glycan structures, and creating innovative software and analytical platforms. The research aims to advance understanding of glycan interactions in biological systems, potentially transforming diagnostic and therapeutic approaches in areas such as cancer research, by providing researchers with more sophisticated tools to study complex cellular glycosylation processes.
Quick answers
Is Z Biotech, LLC registered in SAM.gov?
Yes. Z Biotech, LLC's SAM.gov registration is active through August 8, 2027.
What is Z Biotech, LLC's CAGE code?
Z Biotech, LLC's CAGE code is 704Q5, and its Unique Entity ID (UEI) is KTUKAUTZVRJ3.
What is Z Biotech, LLC's most recent federal award?
Z Biotech, LLC's most recent federal grant award is Development of taca glycan library and related glycomics products (R43GM161150), from National Institute of General Medical Sciences (NIH), on September 1, 2025.
On GovTribe
See Z Biotech, LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors